Solara Active Pharma Sciences Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹249.18Cr |
Net Profits | ₹-275.34Cr |
Net Profit Margins | -110.50% |
Highlights
Solara Active Pharma Sciences Ltd’s revenue fell -38% since last year same period to ₹249.18Cr in the Q3 2023-2024. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated -41.56% fall in its revenue since last 3-months.
Solara Active Pharma Sciences Ltd’s net profit fell -61286.67% since last year same period to ₹-275.34Cr in the Q3 2023-2024. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated -1504.55% fall in its net profits since last 3-months.
Solara Active Pharma Sciences Ltd’s net profit margin fell -98792.29% since last year same period to -110.50% in the Q3 2023-2024. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated -2645.85% fall in its net profit margins since last 3-months.
